We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+10.14%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$34.9B
AUM Growth
+$1.28B
Cap. Flow
-$1.64B
Cap. Flow %
-4.71%
Top 10 Hldgs %
9.34%
Holding
1,542
New
95
Increased
448
Reduced
551
Closed
107

Top Buys

Rank Stock Value
1
GCO icon
Genesco
GCO
+$91.8M
2
SCSC icon
Scansource
SCSC
+$41.1M
3
VMI icon
Valmont Industries
VMI
+$41M
4
LF
LEAPFROG ENTERPRISES INC.
LF
+$40.5M
5
SYNA icon
Synaptics
SYNA
+$37.8M

Sector Composition

Rank Sector Weight
1 Industrials 23.74%
2 Technology 16.6%
3 Consumer Discretionary 13.09%
4 Financials 9.75%
5 Materials 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BELFB
1026
Bel Fuse Inc Class B
BELFB
$3.85B
$2.48M 0.01%
116,300
BELFA icon
1027
Bel Fuse Inc Class A
BELFA
$3.25B
$2.46M 0.01%
126,727
-36,672
-22% -$719K
BTUI
1028
DELISTED
BTU INTERNATIONAL INC
BTUI
$2.46M 0.01%
842,141
SHLD
1029
DELISTED
Sears Holding Corporation
SHLD
$2.45M 0.01%
66,246
-13,249
-17% -$558K
ENTR
1030
DELISTED
ENTROPIC COMMUNICATIONS INC COM STK (DE)
ENTR
$2.44M 0.01%
519,200
CCG
1031
DELISTED
CAMPUS CREST COMMUNITIES INC COM STK (MD)
CCG
$2.44M 0.01%
259,500
+19,500
+8% +$191K
REI icon
1032
Ring Energy
REI
$312M
$2.44M 0.01%
+200,000
New +$2.55M
PII icon
1033
Polaris
PII
$4.16B
$2.43M 0.01%
16,700
-3,600
-18% -$482K
UTMD icon
1034
Utah Medical Products
UTMD
$222M
$2.42M 0.01%
42,300
SCHW
1035
Charles Schwab
SCHW
$177B
$2.4M 0.01%
92,356
-6,800
-7% -$162K
GNSS icon
1036
Genasys
GNSS
$78.3M
$2.4M 0.01%
1,275,000
+350,000
+38% +$589K
PETS icon
1037
PetMed Express
PETS
$42.1M
$2.35M 0.01%
141,000
+85,000
+152% +$1.33M
VVUS
1038
DELISTED
Vivus Inc
VVUS
$2.34M 0.01%
25,800
-24,200
-48% -$2.34M
POWR
1039
DELISTED
POWERSECURE INTL INC COM STK (DE)
POWR
$2.32M 0.01%
135,100
+125,300
+1,279% +$2.15M
CAMP
1040
DELISTED
CalAmp Corp.
CAMP
$2.3M 0.01%
3,578
-1,379
-28% -$769K
DLIA
1041
DELISTED
DELIA*S INC
DLIA
$2.29M 0.01%
2,607,395
+198,300
+8% +$237K
GEOS icon
1042
Geospace Technologies
GEOS
$88M
$2.28M 0.01%
24,074
-1,300
-5% -$120K
GFIG
1043
DELISTED
GFI GROUP INC
GFIG
$2.27M 0.01%
580,000
CALX icon
1044
Calix
CALX
$2.5B
$2.27M 0.01%
+235,000
New +$2.51M
NSR
1045
DELISTED
Neustar Inc
NSR
$2.24M 0.01%
44,987
SZYM
1046
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
$2.23M 0.01%
204,947
+189,947
+1,266% +$1.87M
ANFI
1047
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$2.23M 0.01%
141,476
-193,500
-58% -$2.83M
NVDQ
1048
DELISTED
Novadaq Technologies Inc.
NVDQ
$2.23M 0.01%
135,000
EGY icon
1049
Vaalco Energy
EGY
$567M
$2.21M 0.01%
321,200
GRA
1050
DELISTED
W.R. Grace & Co.
GRA
$2.21M 0.01%
22,300

Similar funds

Royce & Associates's Q4 2013 Portfolio in Review

As of Q4 2013, Royce & Associates held 1,542 positions worth $34.9B, up 3.8% from $33.6B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Royce & Associates withdrew a net $1.64B in Q4 2013, closing 107 positions and reducing 551 holdings. Its most notable exit was JOS A BANK CLOTHIERS INC, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Scansource worth $44.2M.

  • Royce & Associates's largest Q4 2013 buy was Scansource: 1,041,300 shares worth $44.2M.
  • Royce & Associates added most to Genesco in Q4 2013, an estimated $91.8M increase.
  • Royce & Associates's biggest Q4 2013 reduction was Nu Skin, cutting an estimated $215M.
  • Royce & Associates fully exited JOS A BANK CLOTHIERS INC in Q4 2013, selling an estimated $121M.
  • Royce & Associates's ten largest holdings make up 9.3% of its $34.9B portfolio in Q4 2013.
  • Royce & Associates opened 95 new positions and closed 107 in Q4 2013.
  • Royce & Associates's portfolio value rose 3.8% quarter-over-quarter to $34.9B.

Based on Royce & Associates's 13F filing for Q4 2013, filed 10 Feb 2014.